Marketing Communications
and Public Relations for
the convergence of information
technology and the life sciences

Healthcare, pharmaceutical, biotech, and bioinformatics startups are measured and evaluated by more than financial parameters. The right communications strategy and tactical execution can greatly impact how well a young company makes its initial impressions on potential investors, partners, customers, as well as regulators (think HIPAA or 21CFR11).

Biotech Marcom focuses on building a company's reputation with the press and other influencers, establishing credibility and building lasting relationships. Our team members are all senior practitioners with years of relevant experience on such accounts as Blue Cross Blue Shield, L&H Healthcare Solutions Group, Biotechnology Industry Organization, Johnson & Johnson, Roche Diagnostics, Bristol Myers Squibb, Schering-Plough, Carolina Medicorp, Republic Health Corporation, NeXstar Pharmaceuticals, and more.

Whether creating awareness of an illness that a healthcare or pharmaceutical company is fighting, proving to consumers and regulatory bodies that a new biotechnology is safe and ethical, or building media mindshare and market acceptance, successful marketing communications practitioners and programs must be able to look at the immediate horizon and the big picture.

Millions of dollars can ride on each marketing communications decision. Truly competitive biotechs realize that junior practitioners with a few years of general PR exposure cannot add the kind of value that comes from the years of relevant experience that we deliver.

Biotech Marcom brings years of direct industry experience, along with a wealth of understanding of government and public affairs. We're also specialists at meeting the marketing communications needs of emerging companies. Our business model eliminates typical agency inefficiencies so clients pay for results, not a conference room view. They are billed only for the services they use, when they use them.